If you are not happy with the below results, you may try another search.
We have found some results with the word you searched.
Con el lema “Imparables contra los síndromes mielodisplásicos” te invitamos a conocer diversas iniciativas que hemos podido realizar desde la Fundación Josep Carreras y desde el Grupo Español de Síndromes Mielodisplásicos (GESMD) con ánimo de seguir mejorando la información disponible para los pacientes de síndromes mielodisplásicos, un tipo de cáncer de la sangre que afecta […]
Researchers of the Hospital Universitario 12 de Octubre in Madrid and the Josep Carreras Leukaemia Research Institute have developed a cell therapy for a type of leukemia which currently has very few treatment options.
►A study led Dr. Anna Bigas, Principal Investigator of the Stem Cell and Cancer Research Group at Josep Carreras Leukaemia Research Institute and Hospital del Mar Medical Research Institute, has revealed the key role a protein plays in identifying patients with T-cell acute lymphoblastic leukemia who will not respond to standard treatment. ►The study, published […]
►OneChain Immunotherapeutics (OCI) has obtained authorisation for the CARxALL clinical trial to evaluate a new CAR-T therapy for patients who have T-cell leukaemia and no therapeutic alternatives. This clinical trial is the first of the developments being carried out by OCI, which was founded only two years ago. ►OneChain Immunotherapeutics is a spin-off founded by […]
Josep Carreras Leukaemia Research Institute Inicio Creation Board of Trustees Foundation financial contribution Juanxo, 25 years old Acute lymphoblastic leukaemia. “I am here, and I remain unstoppable thanks to research. I was diagnosed with leukaemia when I was 19 and underwent a bone marrow transplant from an anonymous donor located by the Foundation. But I […]
I want to receive the latest news
(+34) 93 414 55 66
Contact
Espacio socios y amigos
